FDA-cleared PreClara™ Ratio (sFlt-1/PlGF) biomarker test offers clinicians a crucial tool for managing hypertensive disorders of pregnancy, with potential significant cost savings and improved patient ...

DUBLIN, Ireland, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech (TRIB), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today ...

Company advances its mission to deliver next-generation diabetes management solutions and expand global market penetration Next-generation column technology enhances efficiency, expands recurring ...

Trinity Biotech (TRIB) has released an update. Trinity Biotech has made a strategic investment of $2.5 million to acquire a 12.5% equity stake in Novus Diagnostics, a company developing rapid sepsis ...

Next-generation column technology enhances efficiency, expands recurring revenue potential, and strengthens Trinity Biotech’s competitive position in the $2B+ HbA1c market DUBLIN, Dec. 15, 2025 (GLOBE ...

HARTFORD, CT — Trinity Health of New England is expanding its mobile coronavirus testing program along with Charter Oak Health Center by serving 19 locations. The goal of the program is to test ...

SPRINGFIELD, Mass. (WWLP) – Trinity Health of New England is increasing their COVID-19 testing capacity. According to a news release sent to 22News, the health system announced Wednesday that the ...

“This 3rd-generation TRINITY technology could be a game-changer for TAVI.” Prof. Dr. Christian Hengstenberg, MD, German Heart Center, Munich (Note: Prof. Dr. med Hengstenberg has no financial ties to ...